45 related articles for article (PubMed ID: 21474179)
1. Hematologic improvement and response in elderly AML/RAEB patients treated with valproic acid and low-dose Ara-C.
Corsetti MT; Salvi F; Perticone S; Baraldi A; De Paoli L; Gatto S; Pietrasanta D; Pini M; Primon V; Zallio F; Tonso A; Alvaro MG; Ciravegna G; Levis A
Leuk Res; 2011 Aug; 35(8):991-7. PubMed ID: 21474179
[TBL] [Abstract][Full Text] [Related]
2. A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis.
Kuo KH; Callum JL; Panzarella T; Jacks LM; Brandwein J; Crump M; Curtis JE; Gupta V; Lipton JH; Minden MD; Sher GD; Schimmer AD; Schuh AC; Yee KW; Keating A; Messner HA
Br J Haematol; 2015 Feb; 168(3):384-94. PubMed ID: 25303497
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients.
Tassara M; Döhner K; Brossart P; Held G; Götze K; Horst HA; Ringhoffer M; Köhne CH; Kremers S; Raghavachar A; Wulf G; Kirchen H; Nachbaur D; Derigs HG; Wattad M; Koller E; Brugger W; Matzdorff A; Greil R; Heil G; Paschka P; Gaidzik VI; Göttlicher M; Döhner H; Schlenk RF
Blood; 2014 Jun; 123(26):4027-36. PubMed ID: 24797300
[TBL] [Abstract][Full Text] [Related]
4. Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis.
Oberoi S; Lehrnbecher T; Phillips B; Hitzler J; Ethier MC; Beyene J; Sung L
Leuk Res; 2014 Apr; 38(4):460-8. PubMed ID: 24472688
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid combined with cytosine arabinoside in elderly patients with acute myeloid leukemia has in vitro but limited clinical activity.
Lane S; Gill D; McMillan NA; Saunders N; Murphy R; Spurr T; Keane C; Fan HM; Mollee P
Leuk Lymphoma; 2012 Jun; 53(6):1077-83. PubMed ID: 22098405
[TBL] [Abstract][Full Text] [Related]
6. Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial.
Wei AH; Montesinos P; Ivanov V; DiNardo CD; Novak J; Laribi K; Kim I; Stevens DA; Fiedler W; Pagoni M; Samoilova O; Hu Y; Anagnostopoulos A; Bergeron J; Hou JZ; Murthy V; Yamauchi T; McDonald A; Chyla B; Gopalakrishnan S; Jiang Q; Mendes W; Hayslip J; Panayiotidis P
Blood; 2020 Jun; 135(24):2137-2145. PubMed ID: 32219442
[TBL] [Abstract][Full Text] [Related]
7. Treatment of acute leukaemia in adult Jehovah's Witnesses.
El Chaer F; Ballen KK
Br J Haematol; 2020 Sep; 190(5):696-707. PubMed ID: 31693175
[TBL] [Abstract][Full Text] [Related]
8. Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial.
Paschka P; Schlenk RF; Weber D; Benner A; Bullinger L; Heuser M; Gaidzik VI; Thol F; Agrawal M; Teleanu V; Lübbert M; Fiedler W; Radsak M; Krauter J; Horst HA; Greil R; Mayer K; Kündgen A; Martens U; Heil G; Salih HR; Hertenstein B; Schwänen C; Wulf G; Lange E; Pfreundschuh M; Ringhoffer M; Girschikofsky M; Heinicke T; Kraemer D; Göhring G; Ganser A; Döhner K; Döhner H
Leukemia; 2018 Jul; 32(7):1621-1630. PubMed ID: 29720733
[TBL] [Abstract][Full Text] [Related]
9. Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia.
Cogle CR; Scott BL; Boyd T; Garcia-Manero G
Oncologist; 2015 Dec; 20(12):1404-12. PubMed ID: 26463870
[TBL] [Abstract][Full Text] [Related]
10. Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.
Fiskus W; Sharma S; Qi J; Valenta JA; Schaub LJ; Shah B; Peth K; Portier BP; Rodriguez M; Devaraj SG; Zhan M; Sheng J; Iyer SP; Bradner JE; Bhalla KN
Mol Cancer Ther; 2014 May; 13(5):1142-54. PubMed ID: 24435446
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome.
Garcia-Manero G; Tambaro FP; Bekele NB; Yang H; Ravandi F; Jabbour E; Borthakur G; Kadia TM; Konopleva MY; Faderl S; Cortes JE; Brandt M; Hu Y; McCue D; Newsome WM; Pierce SR; de Lima M; Kantarjian HM
J Clin Oncol; 2012 Jun; 30(18):2204-10. PubMed ID: 22585696
[TBL] [Abstract][Full Text] [Related]
12. Telomerase Inhibition in the Treatment of Leukemia: A Comprehensive Review.
Bartoszewska E; Molik K; Woźniak M; Choromańska A
Antioxidants (Basel); 2024 Mar; 13(4):. PubMed ID: 38671875
[TBL] [Abstract][Full Text] [Related]
13. The evidence for repurposing anti-epileptic drugs to target cancer.
Aroosa M; Malik JA; Ahmed S; Bender O; Ahemad N; Anwar S
Mol Biol Rep; 2023 Sep; 50(9):7667-7680. PubMed ID: 37418080
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Use of Valproic Acid and All-Trans Retinoic Acid in Acute Myeloid Leukemia-Literature Review and Discussion of Possible Use in Relapse after Allogeneic Stem Cell Transplantation.
Bruserud Ø; Tsykunova G; Hernandez-Valladares M; Reikvam H; Tvedt THA
Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34063204
[TBL] [Abstract][Full Text] [Related]
15. Geriatric assessment in older patients with a hematologic malignancy: a systematic review.
Scheepers ERM; Vondeling AM; Thielen N; van der Griend R; Stauder R; Hamaker ME
Haematologica; 2020 Jun; 105(6):1484-1493. PubMed ID: 32381581
[TBL] [Abstract][Full Text] [Related]
16. HDAC Inhibitors in Acute Myeloid Leukemia.
San José-Enériz E; Gimenez-Camino N; Agirre X; Prosper F
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31739588
[TBL] [Abstract][Full Text] [Related]
17. Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies.
Liu MA; DuMontier C; Murillo A; Hshieh TT; Bean JF; Soiffer RJ; Stone RM; Abel GA; Driver JA
Blood; 2019 Jul; 134(4):374-382. PubMed ID: 31167800
[TBL] [Abstract][Full Text] [Related]
18. Modulation of phospho-proteins by interferon-alpha and valproic acid in acute myeloid leukemia.
Forthun RB; Hellesøy M; Sulen A; Kopperud RK; Sjøholt G; Bruserud Ø; McCormack E; Gjertsen BT
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1729-1749. PubMed ID: 31111215
[TBL] [Abstract][Full Text] [Related]
19. Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia - identification of responders by gene expression profiling of pretreatment leukemic cells.
Reikvam H; Hovland R; Forthun RB; Erdal S; Gjertsen BT; Fredly H; Bruserud Ø
BMC Cancer; 2017 Sep; 17(1):630. PubMed ID: 28877686
[TBL] [Abstract][Full Text] [Related]
20. A clinical challenge: Treatment of acute myeloid leukemia in a Jehovah's Witness.
Cárdenas-Araujo D; González-López EE; González-Leal XJ; Jaime-Pérez JC; Gómez-Almaguer D
Rev Bras Hematol Hemoter; 2016; 38(4):358-360. PubMed ID: 27863765
[No Abstract] [Full Text] [Related]
[Next] [New Search]
